Mean changes from baseline for FACIT-fatigue scores and for EQ-5D utility scores (not pictured) did not reach statistical significance and the improvement seen again in BLISS-52 for these was superior to that seen in BLISS-76.
← all excerpts
Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis.
1
—
—